Kronos Bio, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2019 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Kronos Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2019 to Q3 2024.
- Kronos Bio, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.61M, a 34.4% decline year-over-year.
- Kronos Bio, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $7.49M, a 17.1% decline year-over-year.
- Kronos Bio, Inc. annual Nonoperating Income (Expense) for 2023 was $9.16M, a 134% increase from 2022.
- Kronos Bio, Inc. annual Nonoperating Income (Expense) for 2022 was $3.91M, a 1122% increase from 2021.
- Kronos Bio, Inc. annual Nonoperating Income (Expense) for 2021 was $320K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)